All releases

28 recent releases from TMX Newsfile, newest first, refreshed every 5 minutes. This list follows a fixed rule; nothing in it is chosen, ranked or paid for. Times are Eastern.

Friday, November 6, 2026

9:05 AM ETPhio Pharmaceuticals Corp.NASDAQ: PHIO
Phio Pharmaceuticals Announces Invitation for Oral Presentation at 41st Annual SITC Meeting (Society for Immunotherapy of Cancer)
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today…
TMX NewsfileRead the full release

Thursday, November 5, 2026

4:30 PM ETDoseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70
Doseology Announces Revocation of MCTO and Adoption of Semi-Annual Financial Reporting
Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") announces revocation of the management cease trade order ("MCTO") previously issued on October 29, 2026; and its intention to…
TMX NewsfileRead the full release
4:05 PM ETiSpecimen Inc.NASDAQ: ISPC
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace connecting scientists who need biospecimens for medical research with a network of healthcare specimen providers, today…
TMX NewsfileRead the full release
4:05 PM ETPhio Pharmaceuticals Corp.NASDAQ: PHIO
Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation
Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing therapeutic products based on its proprietary INTASYL® gene-silencing technology to eliminate cancer, today reported…
TMX NewsfileRead the full release
4:01 PM ETInMed Pharmaceuticals Inc.NASDAQ: INM
InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI"
InMed Pharmaceuticals Inc. (NASDAQ: INM) (now Mentari Therapeutics, Inc.) (the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high…
TMX NewsfileRead the full release
2:52 PM ETDigicann Ventures Inc.CSE: DCNN.X
Digicann Ventures Signs Definitive Share Exchange Agreement with Winning Asia Technology Macau Limited for Proposed Reverse Takeover Transaction
Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company") is pleased to announce that, further to its news release dated June 5, 2026, it has entered into a binding share exchange agreement (the "Definitive…
TMX NewsfileRead the full release
11:31 AM ET
Matricelf Reports Statistically Significant Motor Function Improvement in Preclinical Efficacy Study of Chronic Spinal Cord Injury
63% of treated animals achieved at least five points of motor function improvement versus 11.5% of controls, representing an approximately 5.5 times higher responder rateStatistically significant motor function benefits…
TMX NewsfileRead the full release
9:21 AM ET
Solvonis Therapeutics plc Announces US Patent Office Allows Ketamine Patent Across All Behavioural Addictions
Behavioural addictions estimated to affect over 48 million Americans¹THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED…
TMX NewsfileRead the full release
8:00 AM ETOS Therapies, Inc.NYSE American: OSTX
OS Therapies Completes Requalification of Phase 2b Herlystic (OST-HER2) Drug Substance for Confirmatory Phase 3 Trial
OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or the "Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that it has completed the requalification of drug…
TMX NewsfileRead the full release
7:15 AM ET
Zenith Epigenetics Announces Clinical Trial Collaboration and Supply Agreement with Lilly for Registration Enabling Study of ZEN-3694 and Verzenio(R) (Abemaciclib) in NUT Carcinoma
Zenith Epigenetics Ltd. ("Zenith" or the "Company") today announced that the Company has executed a Clinical Trial Collaboration and Supply Agreement ("CTCSA") with Eli Lilly & Company ("Lilly") for the upcoming…
TMX NewsfileRead the full release
7:00 AM ETNASDAQ: COCH
Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress
Company Reaches Six-Month Milestone in Pivotal Trial of Fully Implanted Cochlear ImplantSecond Module of Modular PMA Application Submitted to FDA Following Quarter EndWhite Bear Lake, Minnesota--(Newsfile Corp. -…
TMX NewsfileRead the full release

Wednesday, November 4, 2026

4:51 PM ETInMed Pharmaceuticals Inc.NASDAQ: INM
InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation
InMed Pharmaceuticals Inc. (NASDAQ: INM) (now Mentari Therapeutics, Inc.) (the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high…
TMX NewsfileRead the full release

Tuesday, November 3, 2026

8:02 AM ETCSE: RHELFSE: 4YXOTCQB: TRUFF
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial
Filament has shipped PEX010 to the Keck School of Medicine of USC for the first order under the expanded supply agreement for its Mindfulness Assisted Psychedelic Therapy trial.Toronto, Ontario--(Newsfile Corp. -…
TMX NewsfileRead the full release
6:30 AM ETCSE: VEXT
Vext Reports Q3 2026 Financial Results; Record Quarterly Revenue of $14.9 Million; Operating Cash Flow of $2.4 Million
Record quarterly revenue of $14.9 million, up 23% from Q2 2026 and 18% year-over-year.Ohio revenue up 37% year-over-year to $10.9 million, led by Fairfield and Company-grown flower.Operating cash flow of $2.4 million…
TMX NewsfileRead the full release
5:00 AM ETHerbal Dispatch Inc.CSE: HERBOTCQB: LUFFFFSE: HA9
Herbal Dispatch Accelerates Veteran Program Growth and Expands Access with New Clinic Partnership
Herbal Dispatch Inc. (CSE: HERB) (OTCQB: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a cannabis commerce and international distribution platform, today issued a progress report on Hero Dispatch…
TMX NewsfileRead the full release

Monday, November 2, 2026

8:30 PM ETNeural Therapeutics Inc.CSE: NURLFSE: HANF
Neural Therapeutics Provides Corporate Update
Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces a change to its Board of Directors and provides updates regarding its previously announced transaction with CWE European Holdings…
TMX NewsfileRead the full release
7:37 AM ETCSE: RHELFSE: 4YX0OTCQB: TRUFF
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing
Filament has completed a new extraction of IBEX011The Company expects Filament to begin stability testing on the new extract shortlyToronto, Ontario--(Newsfile Corp. - November 2, 2026) - Rhelion Life Sciences Corp.…
TMX NewsfileRead the full release
7:00 AM ETMustGrow Biologics Corp.TSXV: MGROOTCQB: MGROFFSE: 0C0
MustGrow Appoints Kevin Helash as Chief Executive Officer
MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, today announced the appointment of Kevin Helash as…
TMX NewsfileRead the full release

Thursday, October 29, 2026

5:30 PM ETDoseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70
Doseology Announces Management Cease Trade Order for Late Filing of Annual Audited Financial Statements
Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company"), a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that it…
TMX NewsfileRead the full release
8:30 AM ET
CBD of Denver Outlines Growth Strategy for BioCannabis, Its Integrated European CBD and CBG Production Platform
CBD of Denver, Inc. (OTCID: CBDD) ("CBD of Denver" or the "Company") today outlined the strategic priorities for BioCannabis, its operating business in Northern Greece, following the commercial relaunch of the…
TMX NewsfileRead the full release
7:00 AM ET
Vext Secures Eighth Ohio Dispensary Location, Reaching the State Maximum
Secures provisional dual-use license for an eighth Ohio dispensary, in Amelia, targeted to open by the end of Q3 2027, subject to regulatory approvalsBrings Vext to eight, the most Ohio allows a single operator; with…
TMX NewsfileRead the full release
6:30 AM ETVext Science, Inc.CSE: VEXTOTCQX: VEXTF
Vext Announces Date for Q3 2026 Financial Results Release
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based specialty retailer operating in the regulated cannabis markets of Ohio and Arizona, today announced that the Company expects to…
TMX NewsfileRead the full release

Wednesday, October 28, 2026

5:53 PM ETDelivra Health Brands Inc.TSXV: DHBOTCQB: DHBUF
Delivra Health Brands Reports FY2026 Financial Results
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer-packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce its financial…
TMX NewsfileRead the full release
8:00 AM ETCSE: RHELFSE: 4YX0OTCQB: TRUFF
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Agreement to Supply PEX010 to Linkoping University for PsiloSAD Trial in Social Anxiety Disorder
Filament has signed a supply and licensing agreement with Linköping University in Sweden for PEX010 in the PsiloSAD clinical trial in social anxiety disorder.Toronto, Ontario--(Newsfile Corp. - October 28, 2026) -…
TMX NewsfileRead the full release

Friday, October 16, 2026

8:55 AM ETCSE: RHELFSE: 4YX0OTCQB: TRUFF
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health to Supply Belgium's First Psilocybin Compassionate Use Program, to Help Open the Door to Patient Access for Treatment-Resistant Depression
Filament has signed an agreement to supply PEX010 to Epsylon ASBL for what the Company believes will be the first program in Belgium to give patients access to psilocybin outside a clinical trial.Filament will offer…
TMX NewsfileRead the full release

Wednesday, October 14, 2026

6:00 PM ETDoseology Sciences Inc.CSE: MOODOTCQB: DOSEFFSE: VU70
Doseology Announces Resignation of Director
Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a consumer product innovation company focused on oral pouch and functional stimulant product technologies, announces that…
TMX NewsfileRead the full release
8:34 AM ETCSE: RHELFSE: 4YXOTCQB: TRUFF
Rhelion Life Sciences Reappoints Dr. Robin Carhart-Harris as Scientific Advisor
Dr. Robin Carhart-Harris has signed a new agreement to serve as Scientific Advisor to Rhelion Life Sciences and its wholly owned subsidiary Filament Health.Toronto, Ontario--(Newsfile Corp. - October 14, 2026) - Rhelion…
TMX NewsfileRead the full release

Thursday, October 8, 2026

6:49 PM ETEntheon Biomedical Corp.CSE: ENBI.X
Entheon Announces Continuance into British Columbia
Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has continued out of the jurisdiction of Canada under the Canada Business Corporations Act…
TMX NewsfileRead the full release